Home › Ironwood starts IBS trial in China, but stock falls on analyst forecast
 

Keywords :   


Ironwood starts IBS trial in China, but stock falls on analyst forecast

2013-09-12 13:48:54| Biotech - Topix.net

Ironwood Pharmaceuticals Inc. has announced a late-stage trial in China seeking to get its irritable bowel syndrome drug approved there, but lost 4 percent of stock value after an analyst firm lowered his price target.

Tags: china stock trial falls

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »